Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32

United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026

Add to watchlist

By person

10 insiders · 17 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Brian Lian

President & CEO

—

$12.64M (5)

−$12.64M

2,572,441

2.21%

$86.09M

+11.1%

Greg Zante

Chief Financial Officer

—

$2.61M (5)

−$2.61M

212,204

0.1819%

$7.10M

+30.9%

Marianna Mancini

Chief Operating Officer

—

$2.51M (5)

−$2.51M

422,760

0.3624%

$14.15M

+13.2%

Matthew W Foehr

Director

—

$561.69K (1) scheduled

−$561.69K

135,186

0.1159%

$4.52M

+21.5%

Neil William Aubuchon

Chief Commercial Officer

$149.91K (1)

—

+$149.91K

4,475

0.0038%

$149.76K

—

Lawson Macartney

Director

—

51,115

0.0438%

$1.71M

+6.6%

Charles A Rowland Jr

Director

—

33,150

0.0284%

$1.11M

+10.5%

J Matthew Singleton

Director

—

12,650

0.0108%

$423.33K

+33.2%

Dorothy Elizabeth Kelly-Gemmell

Director

—

6,333

0.0054%

$211.94K

—

Sarah Kathryn Rouan

Director

—

4,390

0.0038%

$146.91K

—

Viking Therapeutics, Inc.

What the insiders did Net selling

By person